A detailed history of Waypoint Wealth Partners Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Waypoint Wealth Partners Inc. holds 7,553 shares of JNJ stock, worth $1.16 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares
7,553
Previous 2,803 169.46%
Holding current value
$1.16 Million
Previous $409,000 199.27%
% of portfolio
0.34%
Previous 0.12%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$145.48 - $167.38 $691,030 - $795,055
4,750 Added 169.46%
7,553 $1.22 Million
Q2 2024

Jul 24, 2024

SELL
$144.38 - $157.78 $445,989 - $487,382
-3,089 Reduced 52.43%
2,803 $409,000
Q1 2024

Apr 24, 2024

BUY
$155.22 - $162.74 $428,717 - $449,487
2,762 Added 88.24%
5,892 $932,000
Q4 2023

Feb 09, 2024

BUY
$145.6 - $158.88 $23,004 - $25,103
158 Added 5.32%
3,130 $490,000
Q3 2023

Oct 23, 2023

BUY
$155.75 - $174.48 $25,698 - $28,789
165 Added 5.88%
2,972 $462,000
Q1 2023

May 01, 2023

SELL
$151.05 - $180.26 $3,927 - $4,686
-26 Reduced 0.92%
2,807 $435,000
Q4 2022

Feb 01, 2023

SELL
$160.2 - $179.79 $36,846 - $41,351
-230 Reduced 7.51%
2,833 $500,000
Q3 2022

Oct 26, 2022

BUY
$161.33 - $179.52 $1,451 - $1,615
9 Added 0.29%
3,063 $500,000
Q2 2022

Aug 05, 2022

BUY
$168.19 - $186.01 $97,886 - $108,257
582 Added 23.54%
3,054 $542,000
Q1 2022

May 09, 2022

BUY
$158.14 - $179.59 $4,902 - $5,567
31 Added 1.27%
2,472 $438,000
Q4 2021

Feb 09, 2022

SELL
$155.93 - $173.01 $6,704 - $7,439
-43 Reduced 1.73%
2,441 $418,000
Q3 2021

Nov 09, 2021

SELL
$161.5 - $179.47 $22,610 - $25,125
-140 Reduced 5.34%
2,484 $401,000
Q2 2021

Aug 06, 2021

SELL
$159.48 - $171.07 $19,456 - $20,870
-122 Reduced 4.44%
2,624 $432,000
Q1 2021

May 10, 2021

BUY
$153.07 - $170.48 $18,674 - $20,798
122 Added 4.65%
2,746 $451,000
Q4 2020

Jan 29, 2021

BUY
$137.11 - $157.38 $359,776 - $412,965
2,624 New
2,624 $413,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $401B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Waypoint Wealth Partners Inc. Portfolio

Follow Waypoint Wealth Partners Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Waypoint Wealth Partners Inc., based on Form 13F filings with the SEC.

News

Stay updated on Waypoint Wealth Partners Inc. with notifications on news.